iPremom is a Valencia-based molecular diagnostics company spun out of Igenomix that develops blood-based tests to detect pregnancy complications earlier. Its flagship product, MaiRa, assesses preeclampsia risk from as early as week 9 of pregnancy. The company works with clinicians and researchers, including published work in Nature Medicine, to bring early-detection tools to obstetric care.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€15,000,000
Total raised
-
Valuation
-
Employees
2019
Founded
Latest round
Seed - September 2, 2026
Seed - €15,000,000
September 2, 2026 · Read the story
Asabys Partners, APEX Ventures
✓ verified by our desk
Team
GF
Guillermo Ferrando Huertas
CEO
In the news
View all →Open roles
iPremom is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile